A breakthrough gene editing technology known as CRISPR is poised to deliver new medical therapies and agricultural and industrial advancements. Although recent reports of its success in the laboratory are promising, the larger challenge confronting CRISPR may be access to the underlying patent rights. To develop CRISPR technologies, commercial developers must fight or license their way through an intellectual property …